The platinum drugs, cisplatin, carboplatin, and oxaliplatin, prevail in the treatment of cancer,
but new platinum agents have been very slow to enter the clinic. Recently, however, there …

The imaging of specific molecular targets that are associated with cancer should allow
earlier diagnosis and better management of oncology patients. Positron emission …

The major goal for prostate cancer imaging in the next decade is more accurate disease
characterization through the synthesis of anatomic, functional, and molecular imaging …

The up-regulation of rates of choline uptake and phosphorylation in certain malignancies
has motivated the development of positron-labeled choline analogues for noninvasive …

The role of positron emission tomography (PET) during the past decade has evolved rapidly
from a pure research tool to a methodology of enormous clinical potential. Perhaps the most …

Elevated levels of choline (trimethyl-2-hydroxyethylammonium) and choline kinase (CK)
activity in neoplasms have motivated the development of positron-labeled choline analogs …

Background: Preoperative diagnosis of pancreatic adenocarcinoma can be difficult.
Computed tomography (CT) is the standard, noninvasive imaging method for evaluation of …

Imaging of amino acid transport in brain tumours is more sensitive than fluorine-18 2-fluoro-
deoxyglucose positron emission tomography (PET). The most frequently used tracer in this …

Positron emission tomography (PET) is now in routine use in oncology, through the success
of metabolic imaging, mainly with fluorodeoxyglucose (FDG). Clear benefit is obtained with …

This study evaluated the yield of whole-body 18F-FDG PET/CT for the detection of
unexpected 18F-FDG-avid additional primary malignant tumors in patients being evaluated …